Company / Operating Cash Flow per Share
BeOne Medicines Ltd. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.81
FY2025
5-year range
-$1.12 / $0.81
FY2021-FY2025
Trend
+885.7%
vs FY2024
Sector context
#60 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +886% YoY in FY2025, a notable deviation from the 9-year average annual change of -309%.
Based on SEC 10-K filings.
0.81 in FY2025.
Improved from $-0.85 to $0.81 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#60 of 212 in Health CareTop 28% of 212This company $0.81 Sector average $5.28
▼
-84.6% below sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 885.7% year-over-year.
- Ranks #60 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.81 | +885.7% |
| FY2024 | -$0.10 | +87.9% |
| FY2023 | -$0.85 | +23.9% |
| FY2022 | -$1.12 | -4.1% |
| FY2021 | -$1.08 | +32.8% |
| FY2020 | -$1.60 | -65.7% |
| FY2019 | -$0.97 | -4.5% |
| FY2018 | -$0.93 | -3842.1% |
| FY2017 | $0.02 | +103.2% |
| FY2016 | -$0.77 | -113.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026